57 related articles for article (PubMed ID: 7505541)
1. Phosphotyrosyl-proteins in human breast cancer.
Partanen S
Anticancer Res; 1993; 13(5C):1777-80. PubMed ID: 7505541
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine kinase activity in breast cancer and its relation to prognostic indicators.
Kopreski MS; Witters L; Brennan WA; Buckwalter EA; Chinchilli VM; Demers LM; Lipton A
Anticancer Res; 1996; 16(5B):3037-41. PubMed ID: 8920763
[TBL] [Abstract][Full Text] [Related]
3. Histochemically demonstrable phosphotyrosyl-protein phosphatase in normal human breast, in benign breast diseases and in breast cancer.
Partanen S; Pekonen F
Anticancer Res; 1989; 9(3):667-71. PubMed ID: 2548434
[TBL] [Abstract][Full Text] [Related]
4. Histochemically demonstrable protein tyrosine phosphatase in human breast and colorectal cancer: large decrease in its activity in colorectal cancer suggests a tumor suppressor role in colorectal mucosal cells.
Partanen S
Anticancer Res; 1996; 16(2):943-6. PubMed ID: 8687156
[TBL] [Abstract][Full Text] [Related]
5. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
[TBL] [Abstract][Full Text] [Related]
6. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical screening for oncogenic tyrosine kinase activation.
Pulford K; Delsol G; Roncador G; Biddolph S; Jones M; Mason DY
J Pathol; 1999 Apr; 187(5):588-93. PubMed ID: 10398126
[TBL] [Abstract][Full Text] [Related]
8. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis.
Verbeek BS; Vroom TM; Adriaansen-Slot SS; Ottenhoff-Kalff AE; Geertzema JG; Hennipman A; Rijksen G
J Pathol; 1996 Dec; 180(4):383-8. PubMed ID: 9014858
[TBL] [Abstract][Full Text] [Related]
9. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
[TBL] [Abstract][Full Text] [Related]
10. Increase of phosphotyrosine-containing proteins in human carcinomas.
Ogawa R; Ohtsuka M; Sasadaira H; Hirasa M; Yabe H; Uchida H; Watanabe Y
Jpn J Cancer Res; 1985 Nov; 76(11):1049-55. PubMed ID: 2418000
[TBL] [Abstract][Full Text] [Related]
11. [Tyrosine-phosphorylated proteins in human breast carcinoma].
Bretti S; Cappa AP; Comoglio PM; Di Renzo MF
J Nucl Med Allied Sci; 1990; 34(4 Suppl):205-10. PubMed ID: 1709208
[TBL] [Abstract][Full Text] [Related]
12. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
Nakopoulou LL; Alexiadou A; Theodoropoulos GE; Lazaris AC; Tzonou A; Keramopoulos A
J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341
[TBL] [Abstract][Full Text] [Related]
14. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.
Papa V; Gliozzo B; Clark GM; McGuire WL; Moore D; Fujita-Yamaguchi Y; Vigneri R; Goldfine ID; Pezzino V
Cancer Res; 1993 Aug; 53(16):3736-40. PubMed ID: 8339284
[TBL] [Abstract][Full Text] [Related]
16. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assay (IHC) to study C-erbB-2 status of breast cancer using monoclonal antibody CIBCgp185.
Meenakshi A; Kumar RS; Ganesh V; Sivakumar N
Hum Antibodies; 2003; 12(4):123-7. PubMed ID: 15156100
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
[TBL] [Abstract][Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
20. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens.
Verbeek BS; Adriaansen-Slot SS; Rijksen G; Vroom TM
J Pathol; 1997 Oct; 183(2):195-203. PubMed ID: 9390033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
